Certara (United States)

2022–2025 · contract · N02

NINDS, NIH BPN, NIH HEAL AND OTHER NIH NEUROSCIENCE-FOCUSED DRUG DISCOVERY AND DEVELOPMENT PROGRAMS WITH TOXICOLOGY CONSULTING SERVICES

Steve Duddy · Certara (United States) · funded by National Institutes of Health

$160.2k

2022–2023 · contract · N02

NINDS, NIH BPN, NIH HEAL AND OTHER NIH NEUROSCIENCE-FOCUSED DRUG DISCOVERY AND DEVELOPMENT PROGRAMS WITH TOXICOLOGY CONSULTING SERVICES

Steve Duddy · Certara (United States) · funded by National Institutes of Health

$18k

2022–2024 · contract · N02

NINDS, NIH BPN, NIH HEAL AND OTHER NIH NEUROSCIENCE-FOCUSED DRUG DISCOVERY AND DEVELOPMENT PROGRAMS WITH TOXICOLOGY CONSULTING SERVICES

Steve Duddy · Certara (United States) · funded by National Institutes of Health

$12k

2022–2023 · contract · N02

NINDS, NIH BPN, NIH HEAL AND OTHER NIH NEUROSCIENCE-FOCUSED DRUG DISCOVERY AND DEVELOPMENT PROGRAMS WITH TOXICOLOGY CONSULTING SERVICES

Steve Duddy · Certara (United States) · funded by National Institutes of Health

$24k

2022–2024 · contract · N02

NINDS, NIH BPN, NIH HEAL AND OTHER NIH NEUROSCIENCE-FOCUSED DRUG DISCOVERY AND DEVELOPMENT PROGRAMS WITH TOXICOLOGY CONSULTING SERVICES

Steve Duddy · Certara (United States) · funded by National Institutes of Health

$30k

2022–2025 · contract · N02

NINDS, NIH BPN, NIH HEAL AND OTHER NIH NEUROSCIENCE-FOCUSED DRUG DISCOVERY AND DEVELOPMENT PROGRAMS WITH TOXICOLOGY CONSULTING SERVICES

Steve Duddy · Certara (United States) · funded by National Institutes of Health

$45k

2021–2023 · cooperative agreement · U01

Development of machine learning approaches to population pharmacokinetic model selection and evaluation of application to model-based bioequivalence analysis.

Mark E Sale · Certara (United States) · funded by U.S. Food and Drug Administration

$125k

2017 · grant · Humboldt Research Fellowship

Humboldt Research Fellowship (July 2017)

Stefanie Hennig · Certara (United States) · funded by Alexander von Humboldt-Stiftung